Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-07-10 09:18 am Sale |
2023-06-16 | 13G | MELI Kaszek Pioneer Corp MEKA |
DRIEHAUS CAPITAL MANAGEMENT LLC | 0 0.000% |
-2,079,641![]() (Position Closed) |
Filing History |
2023-02-13 10:42 am Purchase |
2022-12-31 | 13G | Xponential Fitness, Inc. XPOF |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,171,620 7.880% |
2,171,620![]() (New Position) |
Filing History |
2023-02-13 10:38 am Purchase |
2022-12-31 | 13G | Sonendo, Inc. SONX |
DRIEHAUS CAPITAL MANAGEMENT LLC | 92 7.400% |
92![]() (New Position) |
Filing History |
2023-02-13 10:35 am Purchase |
2022-12-31 | 13G | Blue Foundry Bancorp BLFY |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,497,522 5.370% |
1,497,522![]() (New Position) |
Filing History |
2023-02-10 12:10 pm Purchase |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,681,797 7.490% |
1,558,568![]() (+49.90%) |
Filing History |
2023-02-10 12:06 pm Purchase |
2022-12-31 | 13G | MELI Kaszek Pioneer Corp MEKA |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,079,641 7.000% |
122,100![]() (+6.24%) |
Filing History |
2023-02-10 12:01 pm Sale |
2022-12-31 | 13G | The Real Good Food Company, Inc. RGF |
DRIEHAUS CAPITAL MANAGEMENT LLC | 60,236 11.660% |
-6,169![]() (-9.29%) |
Filing History |
2023-02-08 11:32 am Purchase |
2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
DRIEHAUS CAPITAL MANAGEMENT LLC | 5,624,744 10.450% |
831,106![]() (+17.34%) |
Filing History |
2022-11-10 09:23 am Sale |
2022-10-31 | 13G | DICE Therapeutics, Inc. DICE |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,915,496 4.020% |
-231,146![]() (-10.77%) |
Filing History |
2022-10-13 1:29 pm Sale |
2022-10-04 | 13G | Calidi Biotherapeutics, Inc. CLDI |
DRIEHAUS CAPITAL MANAGEMENT LLC | 20,000 4.840% |
-80,000![]() (-80.00%) |
Filing History |
2022-10-11 08:55 am Sale |
2022-09-30 | 13G | Calidi Biotherapeutics, Inc. CLDI |
DRIEHAUS CAPITAL MANAGEMENT LLC | 100,000 24.220% |
-50,000![]() (-33.33%) |
Filing History |
2022-07-11 10:28 am Sale |
2022-06-08 | 13G | Elevation Oncology, Inc. ELEV |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,044,244 4.490% |
-458,524![]() (-30.51%) |
Filing History |
2022-06-15 11:28 am Purchase |
2021-11-30 | 13G | The Real Good Food Company, Inc. RGF |
DRIEHAUS CAPITAL MANAGEMENT LLC | 66,405 12.920% |
66,405![]() (New Position) |
Filing History |
2022-06-13 1:50 pm Purchase |
2021-12-31 | 13G | MELI Kaszek Pioneer Corp MEKA |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,957,541 6.590% |
1,957,541![]() (New Position) |
Filing History |
2022-06-10 09:02 am Sale |
2022-05-31 | 13G | Elevation Oncology, Inc. ELEV |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,502,768 6.460% |
-479,695![]() (-24.20%) |
Filing History |
2022-04-08 09:47 am Sale |
2022-03-31 | 13G | ChannelAdvisor Corporation ECOM |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,421,532 4.670% |
-674,297![]() (-32.17%) |
Filing History |
2022-02-14 09:42 am Sale |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,327,112 2.770% |
-712,144![]() (-23.43%) |
Filing History |
2022-02-14 09:28 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
DRIEHAUS CAPITAL MANAGEMENT LLC | 150,000 5.220% |
150,000![]() (New Position) |
Filing History |
2022-02-14 09:24 am Purchase |
2021-12-31 | 13G | DICE Therapeutics, Inc. DICE |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,146,642 5.610% |
2,146,642![]() (New Position) |
Filing History |
2022-02-14 09:19 am Purchase |
2021-12-31 | 13G | Elevation Oncology, Inc. ELEV |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,982,463 8.540% |
1,982,463![]() (New Position) |
Filing History |